Cargando…

Dysglycemia, Not Altered Sex Steroid Hormones, Affects Cognitive Function in Polycystic Ovary Syndrome

CONTEXT: Polycystic ovary syndrome (PCOS) is a complex endocrine condition characterized by multiple reproductive and metabolic abnormalities. Because individual reproductive and metabolic abnormalities modulate working memory in the general population, there is growing interest in whether cognitive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jarrett, Brittany Y, Vantman, Natalie, Mergler, Reid J, Brooks, Eric D, Pierson, Roger A, Chizen, Donna R, Lujan, Marla E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767628/ https://www.ncbi.nlm.nih.gov/pubmed/31583367 http://dx.doi.org/10.1210/js.2019-00112

Ejemplares similares

MON-215 Comparison of Ultrasonographic and Biochemical Markers of Polycystic Ovarian Morphology Across the Phenotypic Spectrum of Polycystic Ovary Syndrome
por: Jarrett, Brittany, et al.
Publicado: (2019)

Assessment of ultrasonographic features of polycystic ovaries is associated with modest levels of inter-observer agreement
por: Lujan, Marla E, et al.
Publicado: (2009)

Improving inter-observer variability in the evaluation of ultrasonographic features of polycystic ovaries
por: Lujan, Marla E, et al.
Publicado: (2008)

Digit ratios by computer-assisted analysis confirm lack of anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndrome
por: Lujan, Marla E, et al.
Publicado: (2010)

MON-213 Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Factors in Reproductive-Age Women with Polycystic Ovary Syndrome (PCOS) Using the 2014 Androgen Excess and PCOS Society Criteria for the Polycystic Ovarian Morphology
por: Kazemi, Maryam, et al.
Publicado: (2019)

Overnight Melatonin Concentration and Sleep Quality Are Associated With Clinical Features of Polycystic Ovary Syndrome
por: Evans, Adam T, et al.
Publicado: (2021)

Overnight Melatonin Concentration and Sleep Quality Are Associated with the Clinical Features of Polycystic Ovary Syndrome
por: Evans, Adam T., et al.
Publicado: (2023)

OR31-01 A Randomized Controlled Trial of a Lifestyle Intervention with Longitudinal Follow up on Ovarian Dysmorphology, Hyperandrogenism, and Menstrual Irregularity in Women with Polycystic Ovary Syndrome
por: Kazemi, Maryam, et al.
Publicado: (2020)

THU638 Comparison Of Body Composition Changes In Response To A Hypocaloric Dietary Intervention In Women With And Without Polycystic Ovary Syndrome
por: Zhang, Jie, et al.
Publicado: (2023)

The role of a pulse-based diet on infertility measures and metabolic syndrome risk: protocol of a randomized clinical trial in women with polycystic ovary syndrome
por: McBreairty, Laura E., et al.
Publicado: (2017)

A Comparison of a Pulse-Based Diet and the Therapeutic Lifestyle Changes Diet in Combination with Exercise and Health Counselling on the Cardio-Metabolic Risk Profile in Women with Polycystic Ovary Syndrome: A Randomized Controlled Trial
por: Kazemi, Maryam, et al.
Publicado: (2018)

Dietary and Physical Activity Behaviors in Women with Polycystic Ovary Syndrome per the New International Evidence-Based Guideline
por: Lin, Annie W., et al.
Publicado: (2019)

SAT-023 Osteosarcopenia in Reproductive-Aged Women with Polycystic Ovary Syndrome: A Multicenter Case-Control Study
por: Kazemi, Maryam, et al.
Publicado: (2020)

Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome
por: Deng, Yuying, et al.
Publicado: (2017)

Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity
por: Gupta, Jyotsna, et al.
Publicado: (2022)

Polycystic ovary syndrome and autism: A test of the prenatal sex steroid theory
por: Cherskov, Adriana, et al.
Publicado: (2018)

Polycystic ovary syndrome is a risk factor for sarcopenic obesity: a case control study
por: McBreairty, Laura E., et al.
Publicado: (2019)

Pathophysiological mechanisms of gonadotropins– and steroid hormones–related genes in etiology of polycystic ovary syndrome
por: Shaaban, Zahra, et al.
Publicado: (2019)

Challenges in diagnosis and understanding of natural history of polycystic ovary syndrome
por: Joham, Anju E., et al.
Publicado: (2022)

Kelulut Honey Regulates Sex Steroid Receptors in a Polycystic Ovary Syndrome Rat Model
por: Kamal, Datu Agasi Mohd, et al.
Publicado: (2022)

Sex Steroid Receptors in Polycystic Ovary Syndrome and Endometriosis: Insights from Laboratory Studies to Clinical Trials
por: Abdul Hamid, Fazilah, et al.
Publicado: (2022)

Effect of a pulse-based diet and aerobic exercise on bone measures and body composition in women with polycystic ovary syndrome: A randomized controlled trial
por: McBreairty, Laura E., et al.
Publicado: (2020)

Relationship between the follicular distribution pattern of polycystic ovaries and the degree of menstrual disturbance and serum sex steroid levels
por: Mills, Ginevra, et al.
Publicado: (2022)

Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
por: Qu, Xianqin, et al.
Publicado: (2020)

Effect of Sex Hormone-Binding Globulin on Polycystic Ovary Syndrome: Mechanisms, Manifestations, Genetics, and Treatment
por: Xing, Chuan, et al.
Publicado: (2022)

An Investigation of Steroid Biosynthesis Pathway Genes in Women with Polycystic Ovary Syndrome
por: Sharma, Priyal, et al.
Publicado: (2022)

The Polycystic Ovary Syndrome: An update on metabolic and hormonal mechanisms
por: Dumitrescu, R, et al.
Publicado: (2015)

Trust in Physicians and Medical Experience Beliefs Differ Between Women With and Without Polycystic Ovary Syndrome
por: Lin, Annie W, et al.
Publicado: (2018)

Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study
por: Kumarendran, Balachandran, et al.
Publicado: (2021)

Dietary α-Linolenic Acid-Rich Flaxseed Oil Exerts Beneficial Effects on Polycystic Ovary Syndrome Through Sex Steroid Hormones—Microbiota—Inflammation Axis in Rats
por: Wang, Ting, et al.
Publicado: (2020)

THU632 Musculoskeletal Composition And Function In Polycystic Ovary Syndrome: Early Evidence From A Prospective Study
por: Kazemi, Maryam, et al.
Publicado: (2023)

The Associations between Sex Hormones and Lipid Profiles in Serum of Women with Different Phenotypes of Polycystic Ovary Syndrome
por: Bizoń, Anna, et al.
Publicado: (2021)

Associations Between Sex Hormone Levels and Autistic Traits in Infertile Patients With Polycystic Ovary Syndrome and Their Offspring
por: Jiang, Lijie, et al.
Publicado: (2022)

LBMON234 Ultrasonographic Criteria In The Diagnosis Of Polycystic Ovary Syndrome: A Systematic Review And Meta Analysis
por: Pea, Jeffrey, et al.
Publicado: (2022)

Dysglycemia and arrhythmias
por: Sun, Dong-Kun, et al.
Publicado: (2023)

11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome
por: O’Reilly, Michael W., et al.
Publicado: (2016)

Polycystic Ovary Syndrome, Affective Symptoms, and Neuroactive Steroids: a Focus on Allopregnanolone
por: Standeven, Lindsay R., et al.
Publicado: (2021)

Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome
por: Dewailly, Didier, et al.
Publicado: (2020)

The role of gonadotropin‐releasing hormone neurons in polycystic ovary syndrome
por: McCartney, Christopher R., et al.
Publicado: (2022)

PMON219 Disparities in Musculoskeletal Health Profiles Across Race and Ethnicity in United States-Based Women with Polycystic Ovary Syndrome per the 2018 International Guideline
por: Kazemi, Maryam, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mb24uethv511vdp6446o8p41ps